Search

everythinglearnresearchcommunity

for

Search:↓

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Surgery and Ayurvedic treatments together effectively healed a scalp cyst without relapse.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Biobran MGN-3 reduces chemotherapy side effects and improves quality of life for breast cancer patients.

Diphencyprone therapy for hair loss can cause vitiligo.

Selenium therapy improved health in cystic fibrosis patients with fewer side effects at a lower dose.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.

Botulinum neurotoxin injections into the pelvic muscles successfully prevented priapism relapse for over six months.

Chikungunya virus often causes skin issues and inflammation.

A multidisciplinary approach effectively improves trichotillomania without side effects.

Ion sequential therapy improves heart function after a heart attack.

Ayurveda-based care improved quality of life for breast cancer patients without serious side effects.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

A capuchin monkey with a skin infection was successfully treated with itraconazole.

Young patients with Vogt-Koyanagi-Harada syndrome may have poor vision outcomes despite treatment due to frequent recurrences.

Interferon therapy is a promising and safe treatment for hepatitis B in Southeast Asia.

VYC-12L effectively improves skin smoothness, reduces fine lines, and boosts hydration.

Light therapy can effectively treat vitiligo and hair loss caused by a specific medication.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Some alternative therapies for vitiligo show promise but need more research.

A new delivery system makes Curcumin more effective and safer against viruses.

Adding a second method to PROTACs could improve cancer treatment.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

Narrowband UVB therapy significantly improved a child's rare skin condition.

Cannabinoid and steroid-based drugs could be new treatments for Tourette syndrome, but more research is needed to confirm their effectiveness and safety.

Guduchi and Yashtimadhu can reduce chemotherapy side effects.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.